Int J Oral Implantol (Berl). 2024 Nov 19;17(4):383-400.
To retrospectively evaluate the influence of mesiodistal intra-coronal cantilever width of implant-supported single crowns on the implant and restoration complication-free survival rate and the peri-implant soft and hard tissues.
A total of 142 patients with 179 implants in the posterior region were evaluated. The implants were divided into three groups according to intra-coronal cantilever width (Group 1, ≤ 1 mm; Group 2, 1 mm intra-coronal cantilever width 2 mm; Group 3, ≥ 2 mm). Marginal bone loss, complications and clinical parameters were used to evaluate the influence of intra-coronal cantilever width on implant-supported single crowns.
Group 1 included 95 implants, Group 2 was composed of 27 implants and Group 3 comprised 57 implants. A univariate Cox proportional hazards model, assessing implant complication-free survival, indicated a higher complication rate for Group 3 compared to Group 1 (P = 0.009). Furthermore, the marginal bone loss on the cantilever side over the short-term and medium- to long-term follow-up period indicated that intra-coronal cantilever width ≥ 2 mm may be considered a risk factor. From a clinical perspective, compared with Group 3, Groups 1 and 2 exhibited lower incidence rates of bleeding on probing during the medium- to long-term follow-up period (P = 0.003).
Despite its limitations, the present study shows that posterior single implant crowns with mesiodistal intra-coronal cantilevers equal to or higher than 2 mm will present greater marginal bone loss, complications and tissue inflammation.
回顾性评估种植体支持的单冠近远中向冠内支抗宽度对种植体及修复体无并发症生存率和种植体周围软硬组织的影响。
共评估了 142 名患者的 179 个后牙区种植体。根据冠内支抗宽度将种植体分为三组(组 1,≤1mm;组 2,1mm <冠内支抗宽度≤2mm;组 3,冠内支抗宽度>2mm)。采用边缘骨吸收、并发症和临床参数评估冠内支抗宽度对种植体支持的单冠的影响。
组 1 包括 95 个种植体,组 2 由 27 个种植体组成,组 3 由 57 个种植体组成。单变量 Cox 比例风险模型评估种植体无并发症生存率,结果表明组 3 的并发症发生率高于组 1(P=0.009)。此外,短期和中-长期随访中支抗侧的边缘骨吸收表明,冠内支抗宽度≥2mm 可能是一个危险因素。从临床角度来看,与组 3 相比,组 1 和组 2 在中-长期随访期间探诊出血的发生率较低(P=0.003)。
尽管存在局限性,但本研究表明,近远中向冠内支抗等于或大于 2mm 的后牙单种植体冠会出现更大的边缘骨丧失、并发症和组织炎症。